Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company leverages proprietary antibody engineering platforms to generate high-affinity, high-specificity antibodies targeting disease-relevant antigens in Oncology and Immunology.